Results
Jubilant Pharmova FY26 Revenue Up 14% to ₹8,280 Cr
Jubilant Pharmova reported FY26 revenue growth of 14% YoY to ₹8,280 Cr and proposed a dividend of ₹5 per share.
CDMO Sterile Injectables revenue surged 38% driven by Line 3 ramp-up; onboarded a major
